Congress Wealth Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-3,432
Closed -$267K 608
2021
Q4
$267K Buy
+3,432
New +$303K 0.01% 557

Other funds holding EXAS

Congress Wealth Management's EXAS Position: Q1 2022 in Review

Congress Wealth Management sold out of Exact Sciences (EXAS) in Q1 2022, closing a stake of 3,432 shares — an estimated $267K sold.

Congress Wealth Management first reported a position in EXAS in Q4 2021 and held it in 1 quarter. The position peaked at $267K in Q4 2021. 559 funds tracked by Wall St. Rank hold EXAS as of Q1 2022.

  • Congress Wealth Management reported no remaining Exact Sciences position as of Q1 2022 after selling out during the quarter.
  • Congress Wealth Management sold 3,432 Exact Sciences shares in Q1 2022, an estimated $267K.
  • Congress Wealth Management first reported a position in Exact Sciences in Q4 2021 and held it in 1 quarter.
  • Congress Wealth Management's Exact Sciences position peaked at $267K in Q4 2021.
  • 559 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2022.

Based on Congress Wealth Management's 13F filing for Q1 2022, filed 16 May 2022.